跳到正文

Rhenman & Partners Asset Management AB 13F 持仓 · 2026年Q2

Rhenman & Partners Asset Management AB 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 99 只证券,申报市值合计 10.59 亿美元。前几大持仓:UNH(3.67%)、CVS(2.73%)、AZN(2.69%)。本季前 25 大持仓中:新建仓 4 只、增持 12 只、减持 9 只。

排名代码公司市值占组合股数变动
1UNHUNITED HEALTH GROUP INC$38.9M3.67%93,600增持
2CVSCVS HEALTH CORP$28.9M2.73%279,374减持
3AZNASTRAZENECA PLC$28.5M2.69%151,500新建仓
4MRKMERCK & CO INC$27.4M2.59%213,500新建仓
5LLYLILLY ELI & CO$26.8M2.53%22,315减持
6ABBVABBVIE INC$24.4M2.30%96,775增持
7ALHCALIGNMENT HEALTHCARE INC$23.7M2.24%997,083减持
8EWEDWARDS LIFESCIENCES CORP$23.5M2.22%260,000增持
9GILDGILEAD SCIENCES INC$22.5M2.13%178,250增持
10JAZZJAZZ PHARMACEUTICALS PLC$21.1M1.99%87,440增持
11BIIBBIOGEN INC$20.5M1.93%94,850减持
12SYKSTRYKER CORPORATION$20.5M1.93%65,000增持
13BSXBOSTON SCIENTIFIC CORP$19.2M1.81%450,500减持
14JNJJOHNSON & JOHNSON$18.4M1.74%72,500新建仓
15GHGUARDANT HEALTH INC$17.3M1.63%115,000减持
16REGNREGENERON PHARMACEUTICALS$17.1M1.61%27,390减持
17BMRNBIOMARIN PHARMACEUTICAL INC$16.6M1.57%290,500增持
18GKOSGLAUKOS CORP$16.6M1.57%119,000增持
19NRIXNURIX THERAPEUTICS INC$16.6M1.57%684,250增持
20NTRANATERA INC$16.6M1.56%61,050增持
21MIRMMIRUM PHARMACEUTICALS INC$16.3M1.54%139,205增持
22INSMINSMED INC$16.2M1.53%151,960减持
23THCTENET HEALTHCARE CORP$15.9M1.50%85,200增持
24TMOTHERMO FISHER SCIENTIFIC INC$15.8M1.49%31,580减持
25CNCCENTENE CORP DEL$15.7M1.48%244,000新建仓

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR